{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:15:48Z","timestamp":1778883348154,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003121","name":"Ferdowsi University of Mashhad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003121","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["941051"],"award-info":[{"award-number":["941051"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bbrep.2025.102109","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T07:58:49Z","timestamp":1750751929000},"page":"102109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Melphalan improves toxicity of arsenic trioxide in adult T-cell leukemia\/lymphoma cells"],"prefix":"10.1016","volume":"43","author":[{"given":"Faeze","family":"Khodadadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Hadi","family":"Sadeghian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Delbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohadese","family":"Kazemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamide","family":"Koohpaykar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1889-0964","authenticated-orcid":false,"given":"Fatemeh B.","family":"Rassouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.bbrep.2025.102109_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010807","article-title":"The importance of the clinical classification of adult T-cell leukemia\/lymphoma (ATLL) in the prognosis","volume":"16","author":"Oliveira","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"issue":"19","key":"10.1016\/j.bbrep.2025.102109_bib2","first-page":"2299","article-title":"HTLV-1 persistence and the oncogenesis of adult T-cell leukemia\/lymphoma","volume":"141","author":"Bangham","year":"2023","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.bbrep.2025.102109_bib3","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1111\/cas.15097","article-title":"Epidemiology of adult T\u2010cell leukemia\u2010lymphoma in Japan: an updated analysis, 2012\u20102013","volume":"112","author":"Ito","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrep.2025.102109_bib4","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3389\/fmicb.2020.01124","article-title":"Epidemiology of HTLV-1 infection and ATL in Japan: an update","volume":"11","author":"Iwanaga","year":"2020","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.bbrep.2025.102109_bib5","first-page":"509","article-title":"Molecular epidemiology and phylogenetic analysis of human T-lymphotropic virus type 1 in the tax gene and it association with adult t-cell leukemia\/lymphoma disorders","volume":"13","author":"Pourrezaei","year":"2021","journal-title":"Iran. J. Microbiol."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102109_bib6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1182\/blood-2020-140630","article-title":"Epidemiology, clinical features, and outcome of HTLV-1-related adult T-cell leukemia\/lymphoma in Latin America: a study from the Latin American group of lymphoproliferative disorders (GELL)","volume":"136","author":"Malpica Castillo","year":"2020","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bbrep.2025.102109_bib7","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1111\/cas.14869","article-title":"Adult T\u2010cell leukemia\u2010lymphoma as a viral disease: subtypes based on viral aspects","volume":"112","author":"Nosaka","year":"2021","journal-title":"Cancer Sci."},{"issue":"7","key":"10.1016\/j.bbrep.2025.102109_bib8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3390\/pathogens9070543","article-title":"Mechanisms of oncogenesis by HTLV-1 tax","volume":"9","author":"Mohanty","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.bbrep.2025.102109_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3389\/fmicb.2018.00285","article-title":"HTLV deregulation of the NF-\u03baB pathway: an update on tax and antisense proteins role","volume":"9","author":"Fochi","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbrep.2025.102109_bib10","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1111\/febs.14492","article-title":"NF-kappaB signaling mechanisms in HTLV-1-induced adult T-cell leukemia\/lymphoma","volume":"285","author":"Harhaj","year":"2018","journal-title":"FEBS J."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102109_bib11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.virol.2011.02.021","article-title":"Identification of CD44 as a downstream target of noncanonical NF-kappaB pathway activated by human T-cell leukemia virus type 1-encoded tax protein","volume":"413","author":"Zhang","year":"2011","journal-title":"Virol"},{"issue":"8","key":"10.1016\/j.bbrep.2025.102109_bib12","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/PAS.0000000000000871","article-title":"C-MYC and its main ubiquitin ligase, FBXW7, influence cell proliferation and prognosis in adult T-cell leukemia\/lymphoma","volume":"41","author":"Mihashi","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.bbrep.2025.102109_bib13","doi-asserted-by":"crossref","first-page":"18261","DOI":"10.1073\/pnas.0606108103","article-title":"NOTCH1 directly regulates c-MYC and activates a feedforward-loop transcriptional network promoting leukemic cell growth","volume":"103","author":"Palomero","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrep.2025.102109_bib14","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1182\/blood-2014-06-578856","article-title":"Genetic profile of T-cell acute lymphoblastic leukemias with MYC translocations","volume":"124","author":"Starza","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bbrep.2025.102109_bib15","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00277-011-1161-z","article-title":"CD44 in hematological neoplasias","volume":"90","author":"Hertweck","year":"2011","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.bbrep.2025.102109_bib16","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.leukres.2011.05.011","article-title":"Involvement of osteopontin and its signaling molecule CD44 in clinicopathological features of adult T cell leukemia","volume":"35","author":"Chagan-Yasutan","year":"2011","journal-title":"Leukemia Res"},{"key":"10.1016\/j.bbrep.2025.102109_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4137\/BIC.S33376","article-title":"BMI1: a biomarker of hematologic malignancies","volume":"8","author":"Sahasrabuddhe","year":"2016","journal-title":"Biomark Cancer"},{"key":"10.1016\/j.bbrep.2025.102109_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104040","article-title":"Revisiting the role of alkylating agents in multiple myeloma: up-To-Date evidence and future perspectives","volume":"187","author":"Costa","year":"2023","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"9","key":"10.1016\/j.bbrep.2025.102109_bib19","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.3390\/jcm10091841","article-title":"Treatment of multiple myeloma and the role of melphalan in the era of modern therapies-current research and clinical approaches","volume":"10","author":"Poczta","year":"2021","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102109_bib20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1615\/CritRevImmunol.2016017507","article-title":"Immunostimulatory effects of melphalan and usefulness in adoptive cell therapy with antitumor CD4+ T cells","volume":"36","author":"Kuczma","year":"2016","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.bbrep.2025.102109_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.coviro.2022.101289","article-title":"Advances in the treatment of HTLV-1-associated adult T-cell leukemia lymphoma","volume":"58","author":"Phillips","year":"2023","journal-title":"Curr Opin Virol"},{"issue":"10","key":"10.1016\/j.bbrep.2025.102109_bib22","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3390\/biom13101543","article-title":"Understanding the immunopathology of HTLV-1-associated adult T-cell leukemia\/lymphoma: a comprehensive review","volume":"13","author":"Nakahata","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbrep.2025.102109_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41409-019-0446-z","article-title":"VCAP-AMP-VECP as a preferable induction chemotherapy in transplant-eligible patients with aggressive adult T-cell leukemia-lymphoma: a propensity score analysis","author":"Fuji","year":"2019","journal-title":"Bone Marrow Transplant."},{"issue":"12","key":"10.1016\/j.bbrep.2025.102109_bib24","doi-asserted-by":"crossref","first-page":"6604","DOI":"10.3390\/v7122960","article-title":"Recent advances in therapeutic approaches for adult T-cell leukemia\/lymphoma","volume":"7","author":"Kato","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.bbrep.2025.102109_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101901","article-title":"Insights into molecular mechanisms of chemotherapy resistance in cancer","volume":"42","author":"Kar","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bbrep.2025.102109_bib26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.etap.2017.12.011","article-title":"Regulation of ABCG2 by nuclear factor kappa B affects the sensitivity of human lung adenocarcinoma A549 cells to arsenic trioxide","volume":"57","author":"Jiang","year":"2018","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbrep.2025.102109_bib27","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.3390\/ijms13033527","article-title":"Arsenic and antimony transporters in eukaryotes","volume":"13","author":"Maciaszczyk-Dziubinska","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102109_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-61436-x","article-title":"Chemical modification of melphalan as a key to improving treatment of haematological malignancies","volume":"10","author":"Gajek","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2025.102109_bib29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bioorg.2017.01.020","article-title":"Synthesis of dual-action parthenolide prodrugs as potent anticancer agents","volume":"71","author":"Taleghani","year":"2017","journal-title":"Bioorg. Chem."},{"issue":"14","key":"10.1016\/j.bbrep.2025.102109_bib30","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJMoa1611750","article-title":"Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma","volume":"376","author":"Attal","year":"2017","journal-title":"New Eng J Med"},{"issue":"11","key":"10.1016\/j.bbrep.2025.102109_bib31","first-page":"2004","article-title":"Arsenic trioxide shows synergistic anti-myeloma effects when combined with bortezomib and melphalan in vitro and helps overcome resistance of multiple myeloma cells to these treatments in vivo","volume":"104","author":"Campbell","year":"2004","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bbrep.2025.102109_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0302701","article-title":"Sodium arsenite and arsenic trioxide differently affect the oxidative stress of lymphoblastoid cells: an intricate crosstalk between mitochondria, autophagy and cell death","volume":"19","author":"Rainey","year":"2024","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.bbrep.2025.102109_bib33","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1073\/pnas.0813280106","article-title":"Long-term efficacy and safety of all-trans retinoic acid\/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia","volume":"106","author":"Hu","year":"2009","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"9","key":"10.1016\/j.bbrep.2025.102109_bib34","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/cncr.26517","article-title":"A randomized phase 2 trial of a preparative regimen of bortezomib, high\u2010dose melphalan, arsenic trioxide, and ascorbic acid","volume":"118","author":"Sharma","year":"2012","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.bbrep.2025.102109_bib35","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1158\/2326-6066.CIR-14-0112","article-title":"NF-kappaB, an active player in human cancers","volume":"2","author":"Xia","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbrep.2025.102109_bib36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.freeradbiomed.2017.02.039","article-title":"Regulation of STAT3 and NF-\u03baB activations by S-nitrosylation in multiple myeloma","volume":"106","author":"Kim","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbrep.2025.102109_bib37","first-page":"235","article-title":"CD44, hyaluronan, the hematopoietic stem cell, and leukemia-initiating cells","volume":"6","author":"Zoeller","year":"2015","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.bbrep.2025.102109_bib38","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.arcmed.2020.06.002","article-title":"c-Myc inhibition using 10058-F4 increased the sensitivity of acute promyelocytic leukemia cells to arsenic trioxide via blunting PI3K\/NF-\u03baB axis","volume":"51","author":"Sayyadi","year":"2020","journal-title":"Arch. Med. Res."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102109_bib39","first-page":"90","article-title":"Effect of arsenic trioxide on K562 cell proliferation and its mechanism","volume":"25","author":"Wang","year":"2017","journal-title":"Zhongguo shi yan xue ye xue za zhi"},{"issue":"1","key":"10.1016\/j.bbrep.2025.102109_bib40","first-page":"41","article-title":"BMI-1 gene expression in patients with acute and chronic myeloid leukemia in the northeast of Iran","volume":"14","author":"Zafari","year":"2023","journal-title":"Middle East J Cancer"},{"issue":"1","key":"10.1016\/j.bbrep.2025.102109_bib41","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12885-017-3049-3","article-title":"Upregulation of the proto-oncogene Bmi-1 predicts a poor prognosis in pediatric acute lymphoblastic leukemia","volume":"17","author":"Peng","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrep.2025.102109_bib42","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1111\/bph.14991","article-title":"3D structure of the transporter ABCG2-What's new?","volume":"177","author":"Eckenstaler","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"7731","key":"10.1016\/j.bbrep.2025.102109_bib43","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41586-018-0680-3","article-title":"Cryo-EM structures of a human ABCG2 mutant trapped in ATP-Bound and substrate-bound states","volume":"563","author":"Manolaridis","year":"2018","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bbrep.2025.102109_bib44","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3390\/ijms21030759","article-title":"Disruption of the unique ABCG-Family NBD:NBD interface impacts both drug transport and ATP hydrolysis","volume":"21","author":"Kapoor","year":"2020","journal-title":"Int. J. Mol. Sci."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825001967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825001967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:47:11Z","timestamp":1778881631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580825001967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":44,"alternative-id":["S2405580825001967"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.102109","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melphalan improves toxicity of arsenic trioxide in adult T-cell leukemia\/lymphoma cells","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.102109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102109"}}